These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2123068)

  • 1. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
    Aboulghar MA; Mansour RT; Serour GI
    Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
    Tanbo T; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct intraperitoneal insemination in ovarian hyperstimulation cycles induced with gonadotropin-releasing hormone agonist.
    Misao R; Itoh M; Nakanishi Y; Tamaya T
    Clin Exp Obstet Gynecol; 1997; 24(3):133-4. PubMed ID: 9478296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of an GnRH analogue for induction of gonadotrophin ovulatory surge in cycles stimulated with clomiphene citrate and menopausal gonadotropin in an in vitro fertilization program].
    Wołczyński S; Kulikowski M; Syrewicz M; Kuczyński W; Grochowski D; Sola E; Szamatowicz M
    Ginekol Pol; 1994 Oct; 65(10):573-7. PubMed ID: 7729718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.
    Tan SL; Maconochie N; Doyle P; Campbell S; Balen A; Bekir J; Brinsden P; Edwards RG; Jacobs HS
    Am J Obstet Gynecol; 1994 Aug; 171(2):513-20. PubMed ID: 8059833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
    Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
    J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined GnRH analogs/hMG/hCG treatment].
    Braendle W
    Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reproductive outcome following a superhigh response to stimulation in gamete intrafallopian transfer program.
    al-Shawaf T; Nolan A; Nadkarni P; Harper J; Brown J; Guirgis R; Emerson G; Bayly M; Craft I
    J In Vitro Fert Embryo Transf; 1991 Aug; 8(4):202-7. PubMed ID: 1753165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial between GIFT and ovarian stimulation for the treatment of unexplained infertility and failed artificial insemination by donor.
    Hogerzeil HV; Spiekerman JC; de Vries JW; de Schepper G
    Hum Reprod; 1992 Oct; 7(9):1235-9. PubMed ID: 1479004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
    Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
    Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment variables in relation to oocyte maturation: lessons from a clinical micromanipulation-assisted in vitro fertilization program.
    Avrech OM; Goldman GA; Rufas O; Stein A; Amit S; Yoles I; Pinkas H; Fisch B
    J Assist Reprod Genet; 1997 Jul; 14(6):337-42. PubMed ID: 9226513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrhoea using gonadotrophin releasing hormone analogue and human menopausal gonadotrophin.
    Aboulghar MA; Mansour RT; Serour GI; Ramzy AM
    Hum Reprod; 1990 Jul; 5(5):557-60. PubMed ID: 2118543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
    Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonist.
    Gerris J; Jacquemyn Y; Desmedt E; Delbeke L; Buytaert P
    Hum Reprod; 1989 Nov; 4(8):937-40. PubMed ID: 2515211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropins and glucocorticoid therapy for "low responders"--a controlled study.
    Bider D; Blankstein J; Levron J; Tur-Kaspa I
    J Assist Reprod Genet; 1997 Jul; 14(6):328-31. PubMed ID: 9226511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
    Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stimulation of ovulation with gonadotropins].
    Orlova VG
    Akush Ginekol (Mosk); 1980 Sep; (9):3-5. PubMed ID: 6776837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.